Shares of Merck KGaA (OTCMKTS:MKGAY) have been assigned an average rating of “Hold” from the thirteen brokerages that are presently covering the company. Seven analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $59.60.

Separately, Berenberg Bank cut Merck KGaA from a “buy” rating to a “hold” rating in a report on Friday, August 12th.

Shares of Merck KGaA (OTCMKTS:MKGAY) opened at 35.78 on Tuesday. Merck KGaA has a 12-month low of $26.91 and a 12-month high of $37.16. The stock’s 50 day moving average price is $35.82 and its 200 day moving average price is $33.33. The company has a market capitalization of $46.72 billion and a PE ratio of 29.98.

About Merck KGaA

Merck KGaA is a Germany-based company engaged in the pharmaceutical industry. The Company diversifies its activities into four business divisions: Merck Serono; Consumer Health; Merck Millipore, and Performance Materials. Within the Merck Serono division, the Company focuses on therapeutic areas and prescription drugs of chemical and biotechnological origin.

Receive News & Stock Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related stocks with our FREE daily email newsletter.